Growth Metrics

Pacific Biosciences Of California (PACB) Free Cash Flow (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -139.51%
Dec 31, 2025 -7.03%
Sep 30, 2025 37.78%
Jun 30, 2025 34.15%
Mar 31, 2025 -40.84%
Dec 31, 2024 27.78%
Sep 30, 2024 19.85%
Jun 30, 2024 29.94%
Mar 31, 2024 -33.53%
Dec 31, 2023 9.74%
Sep 30, 2023 -49.99%
Jun 30, 2023 55.28%
Mar 31, 2023 -50.32%
Dec 31, 2022 2.64%
Sep 30, 2022 -4.12%
Jun 30, 2022 21.88%
Mar 31, 2022 -139.27%
Jun 30, 2021 26.48%
Mar 31, 2021 -64.03%
Dec 31, 2020 21.88%
Sep 30, 2020 23.91%
Jun 30, 2020 -132.04%
Mar 31, 2020 510.71%
Dec 31, 2019 -1.28%
Sep 30, 2019 0.46%
Jun 30, 2019 31.60%
Mar 31, 2019 -39.51%
Dec 31, 2018 -33.44%
Sep 30, 2018 9.98%
Jun 30, 2018 17.07%
Mar 31, 2018 10.08%
Dec 31, 2017 -0.78%
Sep 30, 2017 -29.76%
Jun 30, 2017 15.94%
Mar 31, 2017 -24.35%
Dec 31, 2016 14.44%
Sep 30, 2016 16.17%
Jun 30, 2016 -4.63%
Mar 31, 2016 -1,201.76%
Dec 31, 2015 90.19%
Sep 30, 2015 -92.08%
Jun 30, 2015 65.69%
Mar 31, 2015 -55.54%
Dec 31, 2014 -146.44%
Sep 30, 2014 54.38%
Jun 30, 2014 15.83%
Mar 31, 2014 -14.02%
Dec 31, 2013 -179.36%
Sep 30, 2013 210.82%
Jun 30, 2013 6.63%
Mar 31, 2013 4.24%
Dec 31, 2012 -2.93%
Sep 30, 2012 24.83%
Jun 30, 2012 -36.95%
Mar 31, 2012 -8.65%
Dec 31, 2011 37.91%
Sep 30, 2011 25.37%
Jun 30, 2011 -0.09%
Mar 31, 2011 13.21%
Dec 31, 2010 -17.11%